1 Study Coverage
    1.1 Biopharmaceutical Buffers Product Introduction
    1.2 Market by Type
        1.2.1 Global Biopharmaceutical Buffers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Sterile Buffer
        1.2.3 Non-sterile Buffer
    1.3 Market by Application
        1.3.1 Global Biopharmaceutical Buffers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Recombinant Proteins
        1.3.3 Monoclonal Antibodies
        1.3.4 Antibiotics
        1.3.5 Probiotics
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Biopharmaceutical Buffers Sales Estimates and Forecasts 2017-2028
    2.2 Global Biopharmaceutical Buffers Revenue Estimates and Forecasts 2017-2028
    2.3 Global Biopharmaceutical Buffers Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Biopharmaceutical Buffers Sales by Region
        2.4.1 Global Biopharmaceutical Buffers Sales by Region (2017-2022)
        2.4.2 Global Sales Biopharmaceutical Buffers by Region (2023-2028)
    2.5 Global Biopharmaceutical Buffers Revenue by Region
        2.5.1 Global Biopharmaceutical Buffers Revenue by Region (2017-2022)
        2.5.2 Global Biopharmaceutical Buffers Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Biopharmaceutical Buffers Sales by Manufacturers
        3.1.1 Global Top Biopharmaceutical Buffers Manufacturers by Sales (2017-2022)
        3.1.2 Global Biopharmaceutical Buffers Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biopharmaceutical Buffers in 2021
    3.2 Global Biopharmaceutical Buffers Revenue by Manufacturers
        3.2.1 Global Biopharmaceutical Buffers Revenue by Manufacturers (2017-2022)
        3.2.2 Global Biopharmaceutical Buffers Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Biopharmaceutical Buffers Revenue in 2021
    3.3 Global Biopharmaceutical Buffers Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Biopharmaceutical Buffers Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Biopharmaceutical Buffers Sales by Type
        4.1.1 Global Biopharmaceutical Buffers Historical Sales by Type (2017-2022)
        4.1.2 Global Biopharmaceutical Buffers Forecasted Sales by Type (2023-2028)
        4.1.3 Global Biopharmaceutical Buffers Sales Market Share by Type (2017-2028)
    4.2 Global Biopharmaceutical Buffers Revenue by Type
        4.2.1 Global Biopharmaceutical Buffers Historical Revenue by Type (2017-2022)
        4.2.2 Global Biopharmaceutical Buffers Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Biopharmaceutical Buffers Revenue Market Share by Type (2017-2028)
    4.3 Global Biopharmaceutical Buffers Price by Type
        4.3.1 Global Biopharmaceutical Buffers Price by Type (2017-2022)
        4.3.2 Global Biopharmaceutical Buffers Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Biopharmaceutical Buffers Sales by Application
        5.1.1 Global Biopharmaceutical Buffers Historical Sales by Application (2017-2022)
        5.1.2 Global Biopharmaceutical Buffers Forecasted Sales by Application (2023-2028)
        5.1.3 Global Biopharmaceutical Buffers Sales Market Share by Application (2017-2028)
    5.2 Global Biopharmaceutical Buffers Revenue by Application
        5.2.1 Global Biopharmaceutical Buffers Historical Revenue by Application (2017-2022)
        5.2.2 Global Biopharmaceutical Buffers Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Biopharmaceutical Buffers Revenue Market Share by Application (2017-2028)
    5.3 Global Biopharmaceutical Buffers Price by Application
        5.3.1 Global Biopharmaceutical Buffers Price by Application (2017-2022)
        5.3.2 Global Biopharmaceutical Buffers Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Biopharmaceutical Buffers Market Size by Type
        6.1.1 North America Biopharmaceutical Buffers Sales by Type (2017-2028)
        6.1.2 North America Biopharmaceutical Buffers Revenue by Type (2017-2028)
    6.2 North America Biopharmaceutical Buffers Market Size by Application
        6.2.1 North America Biopharmaceutical Buffers Sales by Application (2017-2028)
        6.2.2 North America Biopharmaceutical Buffers Revenue by Application (2017-2028)
    6.3 North America Biopharmaceutical Buffers Market Size by Country
        6.3.1 North America Biopharmaceutical Buffers Sales by Country (2017-2028)
        6.3.2 North America Biopharmaceutical Buffers Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Biopharmaceutical Buffers Market Size by Type
        7.1.1 Europe Biopharmaceutical Buffers Sales by Type (2017-2028)
        7.1.2 Europe Biopharmaceutical Buffers Revenue by Type (2017-2028)
    7.2 Europe Biopharmaceutical Buffers Market Size by Application
        7.2.1 Europe Biopharmaceutical Buffers Sales by Application (2017-2028)
        7.2.2 Europe Biopharmaceutical Buffers Revenue by Application (2017-2028)
    7.3 Europe Biopharmaceutical Buffers Market Size by Country
        7.3.1 Europe Biopharmaceutical Buffers Sales by Country (2017-2028)
        7.3.2 Europe Biopharmaceutical Buffers Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Biopharmaceutical Buffers Market Size by Type
        8.1.1 Asia Pacific Biopharmaceutical Buffers Sales by Type (2017-2028)
        8.1.2 Asia Pacific Biopharmaceutical Buffers Revenue by Type (2017-2028)
    8.2 Asia Pacific Biopharmaceutical Buffers Market Size by Application
        8.2.1 Asia Pacific Biopharmaceutical Buffers Sales by Application (2017-2028)
        8.2.2 Asia Pacific Biopharmaceutical Buffers Revenue by Application (2017-2028)
    8.3 Asia Pacific Biopharmaceutical Buffers Market Size by Region
        8.3.1 Asia Pacific Biopharmaceutical Buffers Sales by Region (2017-2028)
        8.3.2 Asia Pacific Biopharmaceutical Buffers Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Biopharmaceutical Buffers Market Size by Type
        9.1.1 Latin America Biopharmaceutical Buffers Sales by Type (2017-2028)
        9.1.2 Latin America Biopharmaceutical Buffers Revenue by Type (2017-2028)
    9.2 Latin America Biopharmaceutical Buffers Market Size by Application
        9.2.1 Latin America Biopharmaceutical Buffers Sales by Application (2017-2028)
        9.2.2 Latin America Biopharmaceutical Buffers Revenue by Application (2017-2028)
    9.3 Latin America Biopharmaceutical Buffers Market Size by Country
        9.3.1 Latin America Biopharmaceutical Buffers Sales by Country (2017-2028)
        9.3.2 Latin America Biopharmaceutical Buffers Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Biopharmaceutical Buffers Market Size by Type
        10.1.1 Middle East and Africa Biopharmaceutical Buffers Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Biopharmaceutical Buffers Revenue by Type (2017-2028)
    10.2 Middle East and Africa Biopharmaceutical Buffers Market Size by Application
        10.2.1 Middle East and Africa Biopharmaceutical Buffers Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Biopharmaceutical Buffers Revenue by Application (2017-2028)
    10.3 Middle East and Africa Biopharmaceutical Buffers Market Size by Country
        10.3.1 Middle East and Africa Biopharmaceutical Buffers Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Biopharmaceutical Buffers Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Corporation Information
        11.1.2 GE Healthcare Overview
        11.1.3 GE Healthcare Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GE Healthcare Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GE Healthcare Recent Developments
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Corporation Information
        11.2.2 Thermo Fisher Scientific Overview
        11.2.3 Thermo Fisher Scientific Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Thermo Fisher Scientific Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Thermo Fisher Scientific Recent Developments
    11.3 Danaher Corporation
        11.3.1 Danaher Corporation Corporation Information
        11.3.2 Danaher Corporation Overview
        11.3.3 Danaher Corporation Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Danaher Corporation Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Danaher Corporation Recent Developments
    11.4 Sartorius StedimBiotech
        11.4.1 Sartorius StedimBiotech Corporation Information
        11.4.2 Sartorius StedimBiotech Overview
        11.4.3 Sartorius StedimBiotech Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sartorius StedimBiotech Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sartorius StedimBiotech Recent Developments
    11.5 Merck
        11.5.1 Merck Corporation Information
        11.5.2 Merck Overview
        11.5.3 Merck Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Merck Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Merck Recent Developments
    11.6 Eppendorf
        11.6.1 Eppendorf Corporation Information
        11.6.2 Eppendorf Overview
        11.6.3 Eppendorf Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Eppendorf Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Eppendorf Recent Developments
    11.7 Roche
        11.7.1 Roche Corporation Information
        11.7.2 Roche Overview
        11.7.3 Roche Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Roche Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Roche Recent Developments
    11.8 Nova Biomedicals
        11.8.1 Nova Biomedicals Corporation Information
        11.8.2 Nova Biomedicals Overview
        11.8.3 Nova Biomedicals Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Nova Biomedicals Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Nova Biomedicals Recent Developments
    11.9 Lonza
        11.9.1 Lonza Corporation Information
        11.9.2 Lonza Overview
        11.9.3 Lonza Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Lonza Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Lonza Recent Developments
    11.10 Becton, and Dickinson and Company
        11.10.1 Becton, and Dickinson and Company Corporation Information
        11.10.2 Becton, and Dickinson and Company Overview
        11.10.3 Becton, and Dickinson and Company Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Becton, and Dickinson and Company Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Becton, and Dickinson and Company Recent Developments
    11.11 GEA
        11.11.1 GEA Corporation Information
        11.11.2 GEA Overview
        11.11.3 GEA Biopharmaceutical Buffers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 GEA Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 GEA Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Biopharmaceutical Buffers Industry Chain Analysis
    12.2 Biopharmaceutical Buffers Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Biopharmaceutical Buffers Production Mode & Process
    12.4 Biopharmaceutical Buffers Sales and Marketing
        12.4.1 Biopharmaceutical Buffers Sales Channels
        12.4.2 Biopharmaceutical Buffers Distributors
    12.5 Biopharmaceutical Buffers Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Biopharmaceutical Buffers Industry Trends
    13.2 Biopharmaceutical Buffers Market Drivers
    13.3 Biopharmaceutical Buffers Market Challenges
    13.4 Biopharmaceutical Buffers Market Restraints
14 Key Findings in The Global Biopharmaceutical Buffers Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Biopharmaceutical Buffers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Sterile Buffer
    Table 3. Major Manufacturers of Non-sterile Buffer
    Table 4. Global Biopharmaceutical Buffers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Biopharmaceutical Buffers Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Biopharmaceutical Buffers Sales by Region (2017-2022) & (K MT)
    Table 7. Global Biopharmaceutical Buffers Sales Market Share by Region (2017-2022)
    Table 8. Global Biopharmaceutical Buffers Sales by Region (2023-2028) & (K MT)
    Table 9. Global Biopharmaceutical Buffers Sales Market Share by Region (2023-2028)
    Table 10. Global Biopharmaceutical Buffers Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Biopharmaceutical Buffers Revenue Market Share by Region (2017-2022)
    Table 12. Global Biopharmaceutical Buffers Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Biopharmaceutical Buffers Revenue Market Share by Region (2023-2028)
    Table 14. Global Biopharmaceutical Buffers Sales by Manufacturers (2017-2022) & (K MT)
    Table 15. Global Biopharmaceutical Buffers Sales Share by Manufacturers (2017-2022)
    Table 16. Global Biopharmaceutical Buffers Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Biopharmaceutical Buffers Revenue Share by Manufacturers (2017-2022)
    Table 18. Biopharmaceutical Buffers Price by Manufacturers (2017-2022) &(USD/MT)
    Table 19. Global Biopharmaceutical Buffers Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Biopharmaceutical Buffers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Buffers as of 2021)
    Table 21. Biopharmaceutical Buffers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Biopharmaceutical Buffers Product Offered
    Table 23. Date of Manufacturers Enter into Biopharmaceutical Buffers Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Biopharmaceutical Buffers Sales by Type (2017-2022) & (K MT)
    Table 26. Global Biopharmaceutical Buffers Sales by Type (2023-2028) & (K MT)
    Table 27. Global Biopharmaceutical Buffers Sales Share by Type (2017-2022)
    Table 28. Global Biopharmaceutical Buffers Sales Share by Type (2023-2028)
    Table 29. Global Biopharmaceutical Buffers Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Biopharmaceutical Buffers Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Biopharmaceutical Buffers Revenue Share by Type (2017-2022)
    Table 32. Global Biopharmaceutical Buffers Revenue Share by Type (2023-2028)
    Table 33. Biopharmaceutical Buffers Price by Type (2017-2022) & (USD/MT)
    Table 34. Global Biopharmaceutical Buffers Price Forecast by Type (2023-2028) & (USD/MT)
    Table 35. Global Biopharmaceutical Buffers Sales by Application (2017-2022) & (K MT)
    Table 36. Global Biopharmaceutical Buffers Sales by Application (2023-2028) & (K MT)
    Table 37. Global Biopharmaceutical Buffers Sales Share by Application (2017-2022)
    Table 38. Global Biopharmaceutical Buffers Sales Share by Application (2023-2028)
    Table 39. Global Biopharmaceutical Buffers Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Biopharmaceutical Buffers Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Biopharmaceutical Buffers Revenue Share by Application (2017-2022)
    Table 42. Global Biopharmaceutical Buffers Revenue Share by Application (2023-2028)
    Table 43. Biopharmaceutical Buffers Price by Application (2017-2022) & (USD/MT)
    Table 44. Global Biopharmaceutical Buffers Price Forecast by Application (2023-2028) & (USD/MT)
    Table 45. North America Biopharmaceutical Buffers Sales by Type (2017-2022) & (K MT)
    Table 46. North America Biopharmaceutical Buffers Sales by Type (2023-2028) & (K MT)
    Table 47. North America Biopharmaceutical Buffers Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Biopharmaceutical Buffers Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Biopharmaceutical Buffers Sales by Application (2017-2022) & (K MT)
    Table 50. North America Biopharmaceutical Buffers Sales by Application (2023-2028) & (K MT)
    Table 51. North America Biopharmaceutical Buffers Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Biopharmaceutical Buffers Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Biopharmaceutical Buffers Sales by Country (2017-2022) & (K MT)
    Table 54. North America Biopharmaceutical Buffers Sales by Country (2023-2028) & (K MT)
    Table 55. North America Biopharmaceutical Buffers Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Biopharmaceutical Buffers Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Biopharmaceutical Buffers Sales by Type (2017-2022) & (K MT)
    Table 58. Europe Biopharmaceutical Buffers Sales by Type (2023-2028) & (K MT)
    Table 59. Europe Biopharmaceutical Buffers Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Biopharmaceutical Buffers Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Biopharmaceutical Buffers Sales by Application (2017-2022) & (K MT)
    Table 62. Europe Biopharmaceutical Buffers Sales by Application (2023-2028) & (K MT)
    Table 63. Europe Biopharmaceutical Buffers Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Biopharmaceutical Buffers Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Biopharmaceutical Buffers Sales by Country (2017-2022) & (K MT)
    Table 66. Europe Biopharmaceutical Buffers Sales by Country (2023-2028) & (K MT)
    Table 67. Europe Biopharmaceutical Buffers Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Biopharmaceutical Buffers Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Biopharmaceutical Buffers Sales by Type (2017-2022) & (K MT)
    Table 70. Asia Pacific Biopharmaceutical Buffers Sales by Type (2023-2028) & (K MT)
    Table 71. Asia Pacific Biopharmaceutical Buffers Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Biopharmaceutical Buffers Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Biopharmaceutical Buffers Sales by Application (2017-2022) & (K MT)
    Table 74. Asia Pacific Biopharmaceutical Buffers Sales by Application (2023-2028) & (K MT)
    Table 75. Asia Pacific Biopharmaceutical Buffers Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Biopharmaceutical Buffers Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Biopharmaceutical Buffers Sales by Region (2017-2022) & (K MT)
    Table 78. Asia Pacific Biopharmaceutical Buffers Sales by Region (2023-2028) & (K MT)
    Table 79. Asia Pacific Biopharmaceutical Buffers Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Biopharmaceutical Buffers Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Biopharmaceutical Buffers Sales by Type (2017-2022) & (K MT)
    Table 82. Latin America Biopharmaceutical Buffers Sales by Type (2023-2028) & (K MT)
    Table 83. Latin America Biopharmaceutical Buffers Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Biopharmaceutical Buffers Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Biopharmaceutical Buffers Sales by Application (2017-2022) & (K MT)
    Table 86. Latin America Biopharmaceutical Buffers Sales by Application (2023-2028) & (K MT)
    Table 87. Latin America Biopharmaceutical Buffers Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Biopharmaceutical Buffers Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Biopharmaceutical Buffers Sales by Country (2017-2022) & (K MT)
    Table 90. Latin America Biopharmaceutical Buffers Sales by Country (2023-2028) & (K MT)
    Table 91. Latin America Biopharmaceutical Buffers Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Biopharmaceutical Buffers Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Biopharmaceutical Buffers Sales by Type (2017-2022) & (K MT)
    Table 94. Middle East and Africa Biopharmaceutical Buffers Sales by Type (2023-2028) & (K MT)
    Table 95. Middle East and Africa Biopharmaceutical Buffers Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Biopharmaceutical Buffers Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Biopharmaceutical Buffers Sales by Application (2017-2022) & (K MT)
    Table 98. Middle East and Africa Biopharmaceutical Buffers Sales by Application (2023-2028) & (K MT)
    Table 99. Middle East and Africa Biopharmaceutical Buffers Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Biopharmaceutical Buffers Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Biopharmaceutical Buffers Sales by Country (2017-2022) & (K MT)
    Table 102. Middle East and Africa Biopharmaceutical Buffers Sales by Country (2023-2028) & (K MT)
    Table 103. Middle East and Africa Biopharmaceutical Buffers Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Biopharmaceutical Buffers Revenue by Country (2023-2028) & (US$ Million)
    Table 105. GE Healthcare Corporation Information
    Table 106. GE Healthcare Description and Major Businesses
    Table 107. GE Healthcare Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 108. GE Healthcare Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. GE Healthcare Recent Developments
    Table 110. Thermo Fisher Scientific Corporation Information
    Table 111. Thermo Fisher Scientific Description and Major Businesses
    Table 112. Thermo Fisher Scientific Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 113. Thermo Fisher Scientific Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Thermo Fisher Scientific Recent Developments
    Table 115. Danaher Corporation Corporation Information
    Table 116. Danaher Corporation Description and Major Businesses
    Table 117. Danaher Corporation Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 118. Danaher Corporation Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Danaher Corporation Recent Developments
    Table 120. Sartorius StedimBiotech Corporation Information
    Table 121. Sartorius StedimBiotech Description and Major Businesses
    Table 122. Sartorius StedimBiotech Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 123. Sartorius StedimBiotech Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Sartorius StedimBiotech Recent Developments
    Table 125. Merck Corporation Information
    Table 126. Merck Description and Major Businesses
    Table 127. Merck Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 128. Merck Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Merck Recent Developments
    Table 130. Eppendorf Corporation Information
    Table 131. Eppendorf Description and Major Businesses
    Table 132. Eppendorf Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 133. Eppendorf Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Eppendorf Recent Developments
    Table 135. Roche Corporation Information
    Table 136. Roche Description and Major Businesses
    Table 137. Roche Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 138. Roche Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Roche Recent Developments
    Table 140. Nova Biomedicals Corporation Information
    Table 141. Nova Biomedicals Description and Major Businesses
    Table 142. Nova Biomedicals Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 143. Nova Biomedicals Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Nova Biomedicals Recent Developments
    Table 145. Lonza Corporation Information
    Table 146. Lonza Description and Major Businesses
    Table 147. Lonza Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 148. Lonza Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Lonza Recent Developments
    Table 150. Becton, and Dickinson and Company Corporation Information
    Table 151. Becton, and Dickinson and Company Description and Major Businesses
    Table 152. Becton, and Dickinson and Company Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 153. Becton, and Dickinson and Company Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Becton, and Dickinson and Company Recent Developments
    Table 155. GEA Corporation Information
    Table 156. GEA Description and Major Businesses
    Table 157. GEA Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 158. GEA Biopharmaceutical Buffers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. GEA Recent Developments
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Biopharmaceutical Buffers Distributors List
    Table 163. Biopharmaceutical Buffers Customers List
    Table 164. Biopharmaceutical Buffers Market Trends
    Table 165. Biopharmaceutical Buffers Market Drivers
    Table 166. Biopharmaceutical Buffers Market Challenges
    Table 167. Biopharmaceutical Buffers Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biopharmaceutical Buffers Product Picture
    Figure 3. Global Biopharmaceutical Buffers Market Share by Type in 2021 & 2028
    Figure 3. Sterile Buffer Product Picture
    Figure 4. Non-sterile Buffer Product Picture
    Figure 5. Global Biopharmaceutical Buffers Market Share by Application in 2021 & 2028
    Figure 6. Recombinant Proteins
    Figure 7. Monoclonal Antibodies
    Figure 8. Antibiotics
    Figure 9. Probiotics
    Figure 10. Other
    Figure 11. Biopharmaceutical Buffers Report Years Considered
    Figure 12. Global Biopharmaceutical Buffers Sales 2017-2028 (K MT)
    Figure 13. Global Biopharmaceutical Buffers Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Biopharmaceutical Buffers Revenue 2017-2028 (US$ Million)
    Figure 15. Global Biopharmaceutical Buffers Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Biopharmaceutical Buffers Sales Market Share by Region (2017-2022)
    Figure 17. Global Biopharmaceutical Buffers Sales Market Share by Region (2023-2028)
    Figure 18. North America Biopharmaceutical Buffers Sales YoY (2017-2028) & (K MT)
    Figure 19. North America Biopharmaceutical Buffers Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Biopharmaceutical Buffers Sales YoY (2017-2028) & (K MT)
    Figure 21. Europe Biopharmaceutical Buffers Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Biopharmaceutical Buffers Sales YoY (2017-2028) & (K MT)
    Figure 23. Asia-Pacific Biopharmaceutical Buffers Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Biopharmaceutical Buffers Sales YoY (2017-2028) & (K MT)
    Figure 25. Latin America Biopharmaceutical Buffers Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Biopharmaceutical Buffers Sales YoY (2017-2028) & (K MT)
    Figure 27. Middle East & Africa Biopharmaceutical Buffers Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Biopharmaceutical Buffers Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Biopharmaceutical Buffers in the World: Market Share by Biopharmaceutical Buffers Revenue in 2021
    Figure 30. Global Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Biopharmaceutical Buffers Sales Market Share by Type (2017-2028)
    Figure 32. Global Biopharmaceutical Buffers Revenue Market Share by Type (2017-2028)
    Figure 33. Global Biopharmaceutical Buffers Sales Market Share by Application (2017-2028)
    Figure 34. Global Biopharmaceutical Buffers Revenue Market Share by Application (2017-2028)
    Figure 35. North America Biopharmaceutical Buffers Sales Market Share by Type (2017-2028)
    Figure 36. North America Biopharmaceutical Buffers Revenue Market Share by Type (2017-2028)
    Figure 37. North America Biopharmaceutical Buffers Sales Market Share by Application (2017-2028)
    Figure 38. North America Biopharmaceutical Buffers Revenue Market Share by Application (2017-2028)
    Figure 39. North America Biopharmaceutical Buffers Sales Share by Country (2017-2028)
    Figure 40. North America Biopharmaceutical Buffers Revenue Share by Country (2017-2028)
    Figure 41. U.S. Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Biopharmaceutical Buffers Sales Market Share by Type (2017-2028)
    Figure 44. Europe Biopharmaceutical Buffers Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Biopharmaceutical Buffers Sales Market Share by Application (2017-2028)
    Figure 46. Europe Biopharmaceutical Buffers Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Biopharmaceutical Buffers Sales Share by Country (2017-2028)
    Figure 48. Europe Biopharmaceutical Buffers Revenue Share by Country (2017-2028)
    Figure 49. Germany Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 50. France Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Biopharmaceutical Buffers Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Biopharmaceutical Buffers Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Biopharmaceutical Buffers Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Biopharmaceutical Buffers Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Biopharmaceutical Buffers Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Biopharmaceutical Buffers Revenue Share by Region (2017-2028)
    Figure 60. China Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 63. India Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Biopharmaceutical Buffers Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Biopharmaceutical Buffers Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Biopharmaceutical Buffers Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Biopharmaceutical Buffers Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Biopharmaceutical Buffers Sales Share by Country (2017-2028)
    Figure 75. Latin America Biopharmaceutical Buffers Revenue Share by Country (2017-2028)
    Figure 76. Mexico Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Biopharmaceutical Buffers Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Biopharmaceutical Buffers Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Biopharmaceutical Buffers Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Biopharmaceutical Buffers Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Biopharmaceutical Buffers Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Biopharmaceutical Buffers Revenue Share by Country (2017-2028)
    Figure 85. Turkey Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Biopharmaceutical Buffers Revenue (2017-2028) & (US$ Million)
    Figure 88. Biopharmaceutical Buffers Value Chain
    Figure 89. Biopharmaceutical Buffers Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed